XML 22 R7.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Performance Shares
Restricted Shares
Common stock
Common stock
Performance Shares
Common stock
Restricted Shares
Paid-in capital
Paid-in capital
Performance Shares
Paid-in capital
Restricted Shares
Retained earnings (accumulated deficit)
Accumulated other comprehensive loss
Balance at beginning of year (in shares) at Dec. 31, 2022       21,780              
Balance at beginning of year at Dec. 31, 2022 $ 240,088     $ 218     $ 274,579     $ 1,145 $ (35,854)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (8,412)                 (8,412)  
Other comprehensive income, net of tax 2,355                   2,355
Performance shares issued to employees and Net issuance of restricted shares granted to employees and directors (in shares)         120 325          
Performance shares issued to employees and Net issuance of restricted shares granted to employees and directors   $ 0 $ 0   $ 1 $ 3   $ (1) $ (3)    
Stock compensation expense 3,690           3,690        
Shares effectively repurchased for required employee withholding taxes (in shares)       (92)              
Shares effectively repurchased for required employee withholding taxes (538)     $ (1)     (537)        
Stock repurchase (in shares)       (320)              
Stock repurchase (2,539)     $ (3)           (2,536)  
Dividends [1] (3,765)                 (3,765)  
Balance at end of year (in shares) at Dec. 31, 2023       21,813              
Balance at end of year at Dec. 31, 2023 230,879     $ 218     277,728     (13,568) (33,499)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (15,165)                 (15,165)  
Other comprehensive income, net of tax 15,184                   15,184
Performance shares issued to employees and Net issuance of restricted shares granted to employees and directors (in shares)         152 302          
Performance shares issued to employees and Net issuance of restricted shares granted to employees and directors   $ 0 $ 0   $ 2 $ 3   $ (2) $ (3)    
Stock compensation expense 3,924           3,924        
Shares effectively repurchased for required employee withholding taxes (in shares)       (111)              
Shares effectively repurchased for required employee withholding taxes (1,082)     $ (1)     (1,081)        
Dividends [1] (3,817)                 (3,817)  
Balance at end of year (in shares) at Dec. 31, 2024       22,156              
Balance at end of year at Dec. 31, 2024 229,923     $ 222     280,566     (32,550) (18,315)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (26,937)                 (26,937)  
Other comprehensive income, net of tax 270                   270
Performance shares issued to employees and Net issuance of restricted shares granted to employees and directors (in shares)       579              
Performance shares issued to employees and Net issuance of restricted shares granted to employees and directors 0     $ 6     (6)        
Stock compensation expense 3,304           3,304        
Shares effectively repurchased for required employee withholding taxes (in shares)       (81)              
Shares effectively repurchased for required employee withholding taxes (416)     $ (1)     (415)        
Dividends [1] (3,867)                 (3,867)  
Balance at end of year (in shares) at Dec. 31, 2025       22,654              
Balance at end of year at Dec. 31, 2025 $ 202,277     $ 227     $ 283,449     $ (63,354) $ (18,045)
[1] Cash dividend declared per share of common stock, were $0.17, $0.17 and $0.17 in 2023, 2024 and 2025, respectively.